Characterization of changes in FibroTest values during treatment with tenofovir alfenamide (TAF) Or tenofovir disproxil fumarate (TDF) in patients with CHB

Simple item page
dc.contributor.authorIzumi, Namiki
dc.contributor.authorTsang, Owen Tak Yin
dc.contributor.authorAhn, Sang Hoon
dc.contributor.authorAngus, Peter W.
dc.contributor.authorFlaherty, John F.
dc.contributor.authorKim, Kyungpil
dc.contributor.authorGaggar, Anuj
dc.contributor.authorSuri, Vithika
dc.contributor.authorSubramanian, Mani
dc.contributor.authorCooper, Curtis
dc.contributor.authorHann, Hie-Won
dc.contributor.authorAcharya, Subrat K.
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi.tr_TR
dc.contributor.researcheridHLH-8209-2023tr_TR
dc.date.accessioned2023-05-17T07:04:33Z
dc.date.available2023-05-17T07:04:33Z
dc.date.issued2016-10
dc.descriptionBu çalışma, 11-15 Kasım 2016 tarihlerinde Boston[Amerika Birleşik Devletleri]’ da düzenlenen 67. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Kongresi‘nde bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.citationIzumi, N, vd. (2016). "Characterization of changes in FibroTest values during treatment with tenofovir alfenamide (TAF) Or tenofovir disproxil fumarate (TDF) in patients with CHB". Hepatology, 64(Supplement 1), 941A-942A.en_US
dc.identifier.endpage942Atr_TR
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.issueSupplement 1en_US
dc.identifier.startpage941Atr_TR
dc.identifier.urihttps://www.natap.org/2016/AASLD/AASLD_92.htm
dc.identifier.urihttp://hdl.handle.net/11452/32689
dc.identifier.volume64tr_TR
dc.identifier.wos000385493804264tr_TR
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt dışıtr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subject.wosGastroenterology & hepatologyen_US
dc.titleCharacterization of changes in FibroTest values during treatment with tenofovir alfenamide (TAF) Or tenofovir disproxil fumarate (TDF) in patients with CHBen_US
dc.typeMeeting Abstract
dc.wos.quartileQ1en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science